FDA approves first-in-class oral antibiotic
The drug is the first in a new class of oral antibiotics for uncomplicated urinary tract infections in nearly three decades.
List view / Grid view
The drug is the first in a new class of oral antibiotics for uncomplicated urinary tract infections in nearly three decades.
Based on its novel mechanism of action, GSK’s gepotidacin could provide a new oral option for the treatment of gonorrhoea.